113 related articles for article (PubMed ID: 30905274)
21. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
Stedman MR; Feuer EJ; Mariotto AB
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238
[TBL] [Abstract][Full Text] [Related]
22. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
23. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
Minicozzi P; Walsh PM; Sánchez MJ; Trama A; Innos K; Marcos-Gragera R; Dimitrova N; Botta L; Johannesen TB; Rossi S; Sant M;
Eur J Cancer; 2018 Apr; 93():127-137. PubMed ID: 29518726
[TBL] [Abstract][Full Text] [Related]
24. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.
Wright CM; Nowak AK; Halkett G; Moorin RE
BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298
[TBL] [Abstract][Full Text] [Related]
25. The effect of multiple primary rules on population-based cancer survival.
Weir HK; Johnson CJ; Thompson TD
Cancer Causes Control; 2013 Jun; 24(6):1231-42. PubMed ID: 23558444
[TBL] [Abstract][Full Text] [Related]
26. Proportion cured models applied to 23 cancer sites in Norway.
Cvancarova M; Aagnes B; Fosså SD; Lambert PC; Møller B; Bray F
Int J Cancer; 2013 Apr; 132(7):1700-10. PubMed ID: 22927104
[TBL] [Abstract][Full Text] [Related]
27. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
28. Cure fraction estimation from the mixture cure models for grouped survival data.
Yu B; Tiwari RC; Cronin KA; Feuer EJ
Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
[TBL] [Abstract][Full Text] [Related]
29. Cure by age and stage at diagnosis for colorectal cancer patients in North West England, 1997-2004: a population-based study.
Shack LG; Shah A; Lambert PC; Rachet B
Cancer Epidemiol; 2012 Dec; 36(6):548-53. PubMed ID: 22819236
[TBL] [Abstract][Full Text] [Related]
30. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
31. Trends in Late Mortality Among Adolescent and Young Adult Cancer Survivors.
Anderson C; Nichols HB
J Natl Cancer Inst; 2020 Oct; 112(10):994-1002. PubMed ID: 32123906
[TBL] [Abstract][Full Text] [Related]
32. Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?
van Erning FN; van Steenbergen LN; Lemmens VEPP; Rutten HJT; Martijn H; van Spronsen DJ; Janssen-Heijnen MLG
Eur J Cancer; 2014 Jul; 50(10):1731-1739. PubMed ID: 24814358
[TBL] [Abstract][Full Text] [Related]
33. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
34. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
[TBL] [Abstract][Full Text] [Related]
35. Differences in Cancer Survival with Relative versus Cause-Specific Approaches: An Update Using More Accurate Life Tables.
Forjaz de Lacerda G; Howlader N; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2019 Sep; 28(9):1544-1551. PubMed ID: 31221717
[TBL] [Abstract][Full Text] [Related]
36. Accounting for Cured Patients in Cost-Effectiveness Analysis.
Othus M; Bansal A; Koepl L; Wagner S; Ramsey S
Value Health; 2017 Apr; 20(4):705-709. PubMed ID: 28408015
[TBL] [Abstract][Full Text] [Related]
37. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
Hu CY; Xing Y; Cormier JN; Chang GJ
Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226
[TBL] [Abstract][Full Text] [Related]
38. Deaths from COPD in patients with cancer: a population-based study.
Zheng Y; Huang Y; Zheng X; Peng J; Chen Y; Yu K; Yang Y; Wang X; Yang X; Qian J; Wang X; Gao X; Wu B
Aging (Albany NY); 2021 Apr; 13(9):12641-12659. PubMed ID: 33910167
[TBL] [Abstract][Full Text] [Related]
39. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Suh E; Stratton KL; Leisenring WM; Nathan PC; Ford JS; Freyer DR; McNeer JL; Stock W; Stovall M; Krull KR; Sklar CA; Neglia JP; Armstrong GT; Oeffinger KC; Robison LL; Henderson TO
Lancet Oncol; 2020 Mar; 21(3):421-435. PubMed ID: 32066543
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study.
Shen C; Wang C; He T; Cai Z; Yin X; Yin Y; Lu D; Zhang B; Zhou Z
World J Surg Oncol; 2020 May; 18(1):88. PubMed ID: 32375797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
